Home

VAUGHN M KAILIAN

CIK 1180429 · President and CEO · last filed 2015-07-21

VAUGHN M KAILIAN is a President and CEO who has filed 12 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for CHMA, was dated Jul 21, 2015. Across all open-market trades the lifetime net is +$15.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $353.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$353.63M

Companies

5

Total Filings

12

Lifetime Open-Market Net

$15.36M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CHIASMA, INC (CHMA) Delisted 10%+ Owner 5,681,544 $3.76 $21.36M $0 1 2015-07-21
Histogen Inc. (CNAT) Delisted 10%+ Owner 1,010,099 — — $9.09M 1 2013-08-01
CEPHALON INC (CEPH) Delisted Director — — — $0 6 2011-10-17
PCRX 10%+ Owner 2,561,084 $25.24 $64.64M $7.50M 1 2011-02-10
MEMY President and CEO 14,228,773 $20.31 $288.99M -$1.23M 3 2008-02-12

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2015-07-21 CHIASMA, INC (CHMA) Delisted Conv (C) +51,133,896 $0 EDGAR
2013-08-01 Histogen Inc. (CNAT) Delisted Mixed +5,960,400 $10.01M EDGAR
2011-10-17 CEPHALON INC (CEPH) Delisted Disp (D) — $0 EDGAR
2011-05-12 CEPHALON INC (CEPH) Delisted Grant (A) — $0 EDGAR
2011-02-10 PCRX Mixed +5,471,922 $7.50M EDGAR
2010-05-21 CEPHALON INC (CEPH) Delisted Grant (A) — $0 EDGAR
2009-05-14 CEPHALON INC (CEPH) Delisted Grant (A) — $0 EDGAR
2008-05-27 CEPHALON INC (CEPH) Delisted Grant (A) — $0 EDGAR
2008-02-12 MEMY Grant (A) — $0 EDGAR
2007-09-14 MEMY Sell (S) −577,440 -$1.23M EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.